Sarepta Opens Research and Manufacturing CenterBy
Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, has opened a new 60,000-square-foot research and manufacturing center in Andover, Massachusetts.
Sarepta says the facility will enhance its research and manufacturing capabilities as it advances its Duchenne muscular dystrophy (DMD) pipeline, comprised of approaches such as gene therapy and utrophin upregulation programs. By the end of 2017, Sarepta hopes to have up to seven investigational DMD treatments in the clinic.
Sarepta also plans to expand its headcount in Andover by 100% over the next 12 to 18 months, adding to the approximately 50 employees currently based in Andover.
Source: Sarepta Therapeutics